• COVID-19 prompts Pfizer to stop enrollment in most studies

    10 days ago - By Fierce Biotech

    Pfizer has paused enrollment in many new and ongoing clinical trials in response to the COVID-19 pandemic, Reuters reports. The action sees Pfizer join Bristol Myers Squibb and Eli Lilly on the list of Big Pharma companies to revise their R&D plans in light of the novel SARS-CoV-2 coronavirus.
    Read more ...